Although the insulinotropic effect of GIP is diminished in patients with type 2 diabetes, studies have found that GIP receptor agonists can induce a degree of weight loss and, when used in combination with GLP-1, can produce synergistic effects, enhancing blood glucose reduction and weight loss
Hoadley ME, Galea J, Singh N, Hulme S, Ajao DO, Rothwell N, et al
Clinical trials reveal that 4.6 times more patients achieved 15% weight loss and 6.4 times more patients achieved 20% weight loss with Wegovy than with liraglutide 3 mg at 68 weeks
New aspects of amino acid metabolism in cancer
The body image crisis Rapid weight loss from Ozempic can lead to unexpected changes in appearance that affect self-perception